CRM migration fears fade as AI products launch
- R&D and Quality Solutions made up 55% of total revenue in recent quarters.
- Commercial Solutions re-accelerated to about 13% year-over-year subscription growth.
- The risk of losing CRM customers to Salesforce is fading as Vault CRM gains traction.
- The main bull case is sticky software for a regulated industry with high switching costs.
- Veeva introduced Falcon for AI agentic labor and Aspen for horizontal CRM.
Strong core and new AI bets
Veeva is a focused cloud software company for life sciences. That focus is its edge. Drug companies and medical device makers use Veeva in regulated work, where changing systems can be costly, slow, and risky.
The growth story previously relied entirely on R&D and Quality Solutions. That segment reached 55% of total revenue in fiscal 2026. This mix shift supports the bull case because R&D and quality tools have a large addressable market.
The hardest part was supposed to be the CRM handoff to Vault CRM. However, Veeva recently reported its best CRM quarter ever with over 180 customers live on the new platform. Commercial subscription revenue re-accelerated to about 13% year-over-year, which suggests competitors are struggling to win these accounts.
Veeva is now adding a new growth pillar called agentic labor through Veeva Falcon, charging for virtual AI labor. It is also incubating Aspen, a new horizontal CRM offering. Finn sees a strong core business and a de-risked CRM handoff, but investors will need to watch the profit margins on the new AI products.
Subscriptions in a regulated niche
Veeva makes most of its money from subscriptions. Customers pay for access to cloud software and data products over contract terms. Subscription services are the vast majority of total revenue. The rest comes from professional services such as setup, training, configuration, and consulting.
The model works because Veeva tools sit inside important workflows. Customers use them for research, development, quality checks, sales, marketing, and data. In life sciences, these systems often need validation, which means the customer proves the system works in a controlled and compliant way. That makes switching harder.
The company is adding a new pillar to this model with Veeva Falcon, treating AI agentic labor as a distinct revenue stream. The same industry focus also creates risk. The top 10 customers made up 28% of total revenue in each of fiscal 2024, 2025, and 2026.
Four clouds and new AI platforms
Veeva Development Cloud
This supports research and development work, including regulated processes before a product reaches the market.
Veeva Quality Cloud
This helps life sciences companies manage quality processes and compliance.
Veeva Commercial Cloud
This covers sales and marketing tools. The product line is performing well as customers move from legacy Veeva CRM to Vault CRM.
Veeva Data Cloud
This provides data products used in commercial work. It sits with Commercial Solutions for reporting.
Veeva Falcon
This is a new AI product that provides agentic labor. Management views it as a fourth pillar of the business model alongside software, data, and consulting.
Aspen
A new horizontal CRM offering built on modern AI architecture, aiming beyond the core life sciences market.
R&D leads the mix
For Q1 FY27, Veeva reported 45% of total revenue from Commercial Solutions and 55% from R&D and Quality Solutions. The top 10 customers were 28% of total revenue in fiscal 2026.
What could break the story
CRM customers leave for Salesforce
Medium impact · Low oddsVeeva is moving CRM customers from its legacy Salesforce-based product to Vault CRM. While Veeva has over 180 customers live on Vault CRM, Salesforce is still trying to win accounts during this window.
Vault CRM migration slips
High impact · Low oddsVault CRM is a strategic move, but large software migrations can run late. If go-lives are weak, Veeva could lose trust in the commercial business.
Unproven AI margins
Medium impact · Medium oddsVeeva Falcon and Aspen are new bets in agentic labor and horizontal CRM. AI products often have different cost structures than traditional software, which could hurt gross margins.
Large customer concentration
Medium impact · Medium oddsThe top 10 customers were 28% of total revenue in fiscal 2026. Losing one large customer, or seeing major customers merge and reduce systems, could hurt growth.
Sensitive data and compliance failures
High impact · Low oddsVeeva handles software and data used in a complex global regulatory setting. A major data security, privacy, or compliance failure could damage trust.
In one breath
What does Veeva Systems do?
Veeva sells cloud software, data tools, and services to life sciences companies. Its products help with work from research and development through sales and marketing.
Why is Veeva moving away from Salesforce?
Veeva's older CRM product was built on Salesforce technology. Veeva is moving customers to Vault CRM, its own platform, so it can control the product more directly and reduce dependence on Salesforce.
What is the biggest risk for Veeva stock?
The biggest watch item is CRM churn during the Vault CRM migration. Salesforce is competing for those same customers, though Veeva recently noted strong momentum for Vault CRM.
Which part of Veeva is growing in importance?
R&D and Quality Solutions is now the larger reporting segment. It made up 55% of total revenue in fiscal 2026 and Q1 FY27.
Sources and research notes
This page combines Finn's company research with public filings and other cited materials. The thesis is reviewed when material company information changes; Finn Scores use the latest available scoring data.
- Thesis reviewed
- August 30, 2026
- Score data
- September 27, 2026
- Reviewed by
- Shivam Bharuka
Comparable Health Information Services companies
Companies near Veeva Systems Inc. in Finn's Health Information Services industry ranking.
